The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries
Open accessAbstract
Background: Hypertension is the leading preventable cause of premature death worldwide. We examined global disparities of hypertension prevalence, awareness, treatment, and control in 2010 and compared secular changes from 2000 to 2010. Methods: We searched MEDLINE from 1995 through 2014 and supplemented with manual searches of retrieved article references. We included 135 population-based studies of 968 419 adults from 90 countries. Sex- and age-specific hypertension prevalences from each country were applied to population data to calculate regional and global numbers of hypertensive adults. Proportions of awareness, treatment, and control from each country were applied to hypertensive populations to obtain regional and global estimates. Results: In 2010, 31.1% (95% confidence interval, 30.0%–32.2%) of the world’s adults had hypertension; 28.5% (27.3%–29.7%) in high-income countries and 31.5% (30.2%–32.9%) in low- and middle-income countries. An estimated 1.39 (1.34–1.44) billion people had hypertension in 2010: 349 (337–361) million in high-income countries and 1.04 (0.99–1.09) billion in low- and middle-income countries. From 2000 to 2010, the age-standardized prevalence of hypertension decreased by 2.6% in high-income countries, but increased by 7.7% in low- and middle-income countries. During the same period, the proportions of awareness (58.2% versus 67.0%), treatment (44.5% versus 55.6%), and control (17.9% versus 28.4%) increased substantially in high-income countries, whereas awareness (32.3% versus 37.9%) and treatment (24.9% versus 29.0%) increased less, and control (8.4% versus 7.7%) even slightly decreased in low- and middle-income countries. Conclusions: Global hypertension disparities are large and increasing. Collaborative efforts are urgently needed to combat the emerging hypertension burden in low- and middle-income countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Despite several initiatives, the prevalence of raised BP and adverse impact on cardiovascular morbidity and mortality are increasing globally, irrespective of income. 4,5”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“When reviewing global figures, an estimated 1.39 billion people had hypertension in 2010. 4”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“The large disparities in the regional burden of hypertension are accompanied by low levels of awareness, treatment and control rates in LMIC, when compared to HIC.”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“with an estimated 349 million with hypertension in HIC and 1.04 billion in LMICs. 4”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“In response to poor global awareness for hypertension (estimated 67% in HIC and 38% in LMIC), 4”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“good BP control was only achieved in less than one-third and one-tenth of patients with hypertension in highincome and lower-income countries, respectively. 4”
In the citing paper
“About 1/4th of adults have high blood pressure”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
In the citing paper
“Between 1.13 and 1.4 billion people had hypertension in 2010 (defined as >140/90 mm Hg.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
In the citing paper
“Worldwide, about half of adults with hypertension are unaware that their blood pressure is high, a situation more dire in low-income countries.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
In the citing paper
“Two-thirds of those living with hypertension are in low- and middle-income countries where most of the world's population lives”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
In the citing paper
“In high-income countries, the average rates of awareness, treatment, and control are 67%, 55.6%, and 28.4%, respectively, while in low- to middle-income countries the rates are 37.9%, 29%, and 7.7%, respectively.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,698
Self-citationForouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S. M., Prosek, J. M., Nádasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,392
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Forouzanfar, M. H., Alexander, L., Anderson, H. R., Bachman, V. F., Biryukov, S., Brauer, M., Burnett, R., Casey, D., Coates, M. M., Cohen, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00128-2 · Cited by 2,701
Global burden of blood-pressure-related disease, 2001
Lawes, C. M. M., Hoorn, S. V., & Rodgers, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60655-8 · Cited by 2,314
Flagged first, then by citations
2 of the 39 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 1,006
Jeong, E. W., Park, S., Yang, Y.-S., Baek, Y.-J., Yun, D.-M., Kim, H. J., Go, G., & Lee, H. G. (2021) · Foods · doi:10.3390/foods10071571 · Cited by 27
Al‐Aswad, L. A., Elgin, C. Y., Patel, V., Popplewell, D., Gopal, K., Gong, D. A., Thomas, Z., Joiner, D. B., Chu, C.-K., Walters, S. P., et al. (2021) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000416 · Cited by 27
Cardiovascular comorbidities in amyotrophic lateral sclerosis: A systematic review
Xu, K., Ji, H., & Hu, N. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.12.021 · Cited by 27
Association between serum manganese levels and diabetes in Chinese adults with hypertension
Chen, H., Cui, Z., Lu, W., Wang, P., Wang, J., Zhou, Z., Zhang, N., Wang, Z., Lin, T.-F., Song, Y., et al. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14520 · Cited by 28
Han, C., Qian, X., Ren, X., Zhang, S., Hu, L., Li, J., Huang, Y., Huang, R., Ooi, K., Lin, H. Q., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02994-1 · Cited by 28
Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV
Xu, Z., Zhou, H., Zhang, Y., Cheng, Z., Wan, M., Qin, W., Li, P., Feng, J., Shao, S.-J., Xue, W., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115752 · Cited by 27
Tu, R., Inoue, Y., Yazawa, A., Hao, X., Cai, G., Li, Y., Lin, X., He, F., & Yamamoto, T. (2018) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13317 · Cited by 27
Effects of flavonoid-rich fruits on hypertension in adults: a systematic review
Ellwood, L., Torun, G., Bahar, Z., & Fernandez, R. S. (2019) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-d-19-00050 · Cited by 27
NAD+ and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities
Abdellatif, M., Bugger, H., Kroemer, G., & Sedej, S. (2022) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2022.11.2.111 · Cited by 26
Wang, K., Ning, X., Qin, C., Wang, J., Yan, W., Zhou, X. J., Wang, D., Cao, J.-M., & Feng, Y. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s378727 · Cited by 30
Epidemiología de la hipertensión arterial
Banegas, J. R., & Gijón‐Conde, T. (2017) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(18)30066-7 · Cited by 26
Chuang, S., Chang, H., Cheng, H., Pan, W., & Chen, C. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx178 · Cited by 26
Ferguson, T., Younger-Coleman, N., Tulloch-Reid, M., Bennett, N., Rousseau, A., Knight-Madden, J., Samms-Vaughan, M., Ashley, D., & Wilks, R. (2018) · PeerJ · doi:10.7717/peerj.4385 · Cited by 25
Hu, J., Zhao, L., Thompson, B. S., Zhang, Y., & Wu, Y. (2018) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2018.1425415 · Cited by 27
Ogola, E. N., Barasa, F. A., Barasa, A. L., Gitura, B., Njunguna, B., Beaney, T. E., Xia, X., & Poulter, N. R. (2019) · European Heart Journal Supplements · doi:10.1093/eurheartj/suz059 · Cited by 26
Jamshidnezhad, A., Kabootarizadeh, L., & Hoseini, S. M. (2019) · Acta Informatica Medica · doi:10.5455/aim.2019.27.263-267 · Cited by 25
Logoyda, L., Коваленко, С. І., Gaafar, M., Abdel‐Megied, A. M., & Elbarbry, F. (2020) · Microchemical Journal · doi:10.1016/j.microc.2020.104700 · Cited by 26
Hypertension in Rural India: The Contribution of Socioeconomic Position
Thrift, A. G., Ragavan, R. S., Riddell, M. A., Joshi, R., Thankappan, K. R., Chow, C. K., Oldenburg, B. F., Mahal, A. S., Kalyanram, K., Kartik, K., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014486 · Cited by 26
Sujarwoto, S., & Maharani, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244333 · Cited by 26
Ravichandran, B., Grimm, D. G., Krüger, M., Kopp, S., Infanger, M., & Wehland, M. (2021) · Physiological Reports · doi:10.14814/phy2.14800 · Cited by 28
Sattartabar, B., Ajam, A., Pashang, M., Jalali, A., Sadeghian, S., Mortazavi, S. H., Mansourian, S., Bagheri, J., Karimi, A., & Hosseini, K. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02273-2 · Cited by 26
Dhungana, R. R., Pandey, A. R., Shrestha, N., Pedišić, Ž., & de Courten, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.716080 · Cited by 27
Feng, Q., Jiang, C., Wang, M., Cai, R., Wang, H., Wu, D., Wang, F., Lin, L., & Nassis, G. P. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258763 · Cited by 26
Degree of Joint Risk Factor Control and Incident Heart Failure in Hypertensive Patients
Kou, M., Wang, X., Ma, H., Li, X., Heianza, Y., & Qi, L. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.01.006 · Cited by 26
Age at First Childbirth and Hypertension in Postmenopausal Women
Park, S. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09182 · Cited by 26
Wu, X. Y., Li, B., Lin, W., Huang, L., Wang, X., Fu, L., Li, B., & Wang, P.-X. (2018) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2018.1489546 · Cited by 26
Song, S., Cai, X., Hu, J., Zhu, Q., Shen, D., Ma, H., Zhang, Y., Ma, R., Yang, W., Hong, J., et al. (2024) · Drug Design, Development and Therapy · doi:10.2147/dddt.s466904 · Cited by 25
Chen, H., Liu, L., Wang, Y., Hong, L., Zhong, W., Lehr, T., Bragazzi, N. L., Tang, B., & Dai, H. (2024) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcae090 · Cited by 29
Miazgowski, T., Kopec, J. A., Widecka, K., Miazgowski, B., & Kaczmarkiewicz, A. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.85222 · Cited by 25
Kim, W., Chang, K., Cho, E. J., Ahn, J.-C., Yu, C. W., Cho, K., Kim, Y.-J., Kang, D., Kim, S., Lee, S., et al. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13774 · Cited by 25
Lee, C. J., Park, W. J., Suh, J., Choi, E., Jeon, D. W., Lim, S., Kim, D., Cha, K. S., Lee, B.-R., Kim, N., et al. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13941 · Cited by 32
Sweileh, W. M. (2020) · International Journal of Mental Health Systems · doi:10.1186/s13033-020-00402-6 · Cited by 25
Akpa, O. M., Okekunle, A. P., Asowata, O. J., & Adedokun, B. (2021) · Clinical Hypertension · doi:10.1186/s40885-020-00159-7 · Cited by 25
Impact of Therapeutic Inertia on Long-Term Blood Pressure Control
Augustin, A., Coutts, L. V., Zanisi, L., Wierzbicki, A. S., Shankar, F., Chowienczyk, P., & Floyd, C. N. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.15866 · Cited by 25
Wang, L., Li, N., Heizhati, M., Li, M., Yang, Z., Wang, Z., & Abudereyimu, R. (2021) · International Journal of Hypertension · doi:10.1155/2021/6652228 · Cited by 25
“04 billion) live in the developing countries [3].”
BackgroundLazaridis, A. A., Gavriilaki, E., Δούμα, Σ., & Gkaliagkousi, Ε. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073451 · Cited by 25
Pippias, M., Stel, V. S., Arnol, M., Bemelman, F. J., Berger, S. P., Buturović‐Ponikvar, J., Kramar, R., Magaz, Á., Nordio, M., Sengers, H. P., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab156 · Cited by 25
Omidi, N., Arabloo, J., Rezapour, A., Alaeddini, F., Bragazzi, N. L., Pourasghari, H., Behzadifar, M., Salarifar, M., Khorgami, M., Ghorashi, S. M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257617 · Cited by 25
Sohail, M. U., Hedin, L., & Al‐Asmakh, M. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s325073 · Cited by 27
Ramatsoma, H., & Patrick, S. M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.857600 · Cited by 25
Galendi, J. S. C., Leite, R. G. O. F., Banzato, L. R., & Nogueira, V. D. S. N. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074243 · Cited by 29
Fujii, R., Hishida, A., Nakatochi, M., Tsuboi, Y., Suzuki, K. A. O., Kondo, T., Ikezaki, H., Hara, M., Okada, R., Tamura, T., et al. (2022) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.121.003612 · Cited by 26
Waki, T., Miura, K., Tanaka‐Mizuno, S., Ohya, Y., Node, K., Itoh, H., Rakugi, H., Sato, J., Goda, K., Kitsuregawa, M., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-00924-1 · Cited by 25
Amoah, I., Lim, J. J., Osei, E. O., Arthur, M., Tawiah, P., Oduro, I., Aduama‐Larbi, M. S., Lowor, S. T., & Rush, E. C. (2022) · Foods · doi:10.3390/foods11131962 · Cited by 25
Oraii, A., Shafiee, A., Jalali, A., Alaeddini, F., Saadat, S., Sadeghian, S., Poorhosseini, H., Boroumand, M. A., Karimi, A., & Franco, O. H. (2022) · Global Heart · doi:10.5334/gh.1120 · Cited by 25
Sources of automatic office blood pressure measurement error: a systematic review
Liu, J., Li, Y., Li, J., Zheng, D., & Liu, C. (2022) · Physiological Measurement · doi:10.1088/1361-6579/ac890e · Cited by 25
Xu, C., Song, G., Hu, D., Li, G., Liu, Q., & Tang, X. (2022) · European Journal of Public Health · doi:10.1093/eurpub/ckac140 · Cited by 25
Kasim, S. S., Malek, S., Song, C., Ahmad, W. A. W., Fong, A. Y. Y., Ibrahim, K. S., Kassim, M. S. S., Aziz, F., Hiew, J. H., & Ibrahim, N. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278944 · Cited by 28
Hu, X., & Zhang, L. (2022) · Antioxidants · doi:10.3390/antiox11122432 · Cited by 22
Peng, N., Kuang, M., Peng, Y., Yu, H., Zhang, S., Xie, G., Sheng, G., & Zou, Y. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1129112 · Cited by 25
Fan, Z., Liao, Z., Zong, X., & Zhang, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210591 · Cited by 26
Shi, S., Li, S., Li, W., & Xu, H. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2915498 · Cited by 25
“High blood pressure (BP), as one of the most common diseases in the world [1], has been recognized as a major risk factor for cardiovascular and cerebrovascular diseases, leading to major health complications such as heart attack, strokes, and renal dysfunction [2–6].”
BackgroundSantiago, E. R. C., Diniz, A. D. S., Oliveira, J. S., Leal, V. S., de Andrade, M. I. S., & de Lira, P. I. C. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190145 · Cited by 25
Kaul, U., Arambam, P., Rao, S., Kapoor, S., Swahney, J. P. S., Sharma, K. H., Nair, T., Chopda, M., Hiremath, J., Ponde, C. K., et al. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0243-6 · Cited by 25
Gala, P., Moshokgo, V., Seth, B., Ramasuana, K., Kazadi, E., M'buse, R., Pharithi, S., Gobotsamang, K., Szymanowski, P., Kerobale, R. O., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013766 · Cited by 24
Vascular ageing in hypertension: Focus on mitochondria
Forte, M., Stanzione, R., Cotugno, M., Bianchi, F., Marchitti, S., & Rubattu, S. D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111267 · Cited by 26
Lifestyle Score and Genetic Factors With Hypertension and Blood Pressure Among Adults in Rural China
Niu, M., Zhang, L., Wang, Y., Tu, R., Liu, X., Wang, C., & Bie, R. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.687174 · Cited by 28
Fan, Y., Wang, L., Liu, H., Zhang, S., Tian, H., Shen, Y., Tuomilehto, J., Yu, Z., Yang, X., Hu, G., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001060 · Cited by 26
Physiological reactivity to acute mental stress in essential hypertension—a systematic review
Walther, L.-M., & Wirtz, P. H. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1215710 · Cited by 35
Serious adverse events in patients with target-oriented blood pressure management
Frey, L. R., Gravestock, I., Pichierri, G., Steurer, J., & Burgstaller, J. M. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002176 · Cited by 23
Fort, M. P., Paniagua-Ávila, A., Beratarrechea, A. G., Cardona, S., Figueroa, J. C., Martínez-Folgar, K., Moyano, D. L., Barrios, E., Mazariegos, B. E., Palacios, E., et al. (2019) · Global Heart · doi:10.1016/j.gheart.2019.05.005 · Cited by 25
Self-citationScholes, S., Conolly, A., & Mindell, J. S. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002350 · Cited by 24
“Inequalities in hypertension prevalence are potentially magnified by inequalities in diagnosis, treatment and control of hypertension, even in countries with universal health coverage [3], reflecting barriers related to the availability, accessibility and affordability of health care, including medication [5,9].”
BackgroundInfluentialSaarinen, A. I. L., Keltikangas‐Järvinen, L., Hintsa, T., Pulkki-Råbäck, L., Ravaja, N., Lehtimäki, T. J., Raitakari, O. T., & Hintsanen, M. (2020) · International Journal of Behavioral Medicine · doi:10.1007/s12529-020-09886-5 · Cited by 25
Wagata, M., Kogure, M., Nakaya, N., Tsuchiya, N., Nakamura, T., Hirata, T., Narita, A., Metoki, H., Ishikuro, M., Kikuya, M., et al. (2020) · Hypertension Research · doi:10.1038/s41440-020-0463-8 · Cited by 24
Digital Health Approaches for the Assessment and Optimization of Hypertension Care Provision.
Padwal, R., & Wood, P. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.12.009 · Cited by 22
Masyuko, S. J., Ngongo, C. J., Smith, C., & Nugent, R. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245269 · Cited by 24
Huang, J., Gu, J.-X., Bao, H., Li, S.-S., Yao, X., Yang, M., Li, Y., Zhang, A., Yin, Y., Zhang, N., et al. (2021) · Disease Markers · doi:10.1155/2021/5597028 · Cited by 24
Periodontal Inflamed Surface Area Mediates the Link between Homocysteine and Blood Pressure
Botelho, J., Machado, V., Leira, Y., Proença, L., & Mendes, J. J. (2021) · Biomolecules · doi:10.3390/biom11060875 · Cited by 24
Jonsson, U., Eek, M. N., Sunnerhagen, K. S., & Himmelmann, K. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.732939 · Cited by 24
Blood pressure and risk of cancer: a Mendelian randomization study
Chan, I. I., Kwok, M. K., & Schooling, C. M. (2021) · BMC Cancer · doi:10.1186/s12885-021-09067-x · Cited by 24
Shi, P., Liu, S., Xia, X., Qian, J., Jing, H., Yuan, J., Zhao, H., Wang, F., Wang, Y., Wang, X., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.153039 · Cited by 24
Prasertsri, P., Phoemsapthawee, J., Kuamsub, S., Poolpol, K., & Boonla, O. (2022) · Journal of Environmental and Public Health · doi:10.1155/2022/5942947 · Cited by 29
Endothelial MicroRNA‐483‐3p Is Hypertension‐Protective
Shang, F., Guo, X., Chen, Y., Wang, C., Gao, J., Wen, E., Lai, B., & Bai, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3698219 · Cited by 24
Metz, M., Pierre, J. L., Yan, L. D., Rouzier, V., St‐Preux, S., Exantus, S., Preval, F., Roberts, N. L. S., Tymejczyk, O., Malebranche, R., et al. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14399 · Cited by 22
Wang, Y., Jiang, Y., Chen, Y., Yu, L., Zhou, J., Wang, N., Liu, T., & Fu, C. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14451 · Cited by 24
“1 mmol/L; (3) hemoglobin A1c (HbA1c) ≥6.”
BackgroundMethodFentaw, Z., Adamu, K., & Wedajo, S. (2022) · BMC Public Health · doi:10.1186/s12889-022-13368-6 · Cited by 24
Amouzegar, A., Abu‐Alfa, A. K., Alrukhaimi, M. N., Bello, A. K., Ghnaimat, M. A., Johnson, D. W., Jha, V., Harris, D. C. H., Levin, A., Tonelli, M. A., et al. (2021) · Kidney International Supplements · doi:10.1016/j.kisu.2021.01.002 · Cited by 24
Primary aldosteronism and pregnancy
Medved, V. І., Kyrylchuk, M. Y., & Husieva, A. Y. (2022) · Reproductive Endocrinology · doi:10.18370/2309-4117.2022.63.39-46 · Cited by 24
Wattanapisit, A., Ng, C. J., Angkurawaranon, C., Wattanapisit, S., Chaovalit, S., & Stoutenberg, M. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11259 · Cited by 31
Effects of curcumin on blood pressure: A systematic review and dose-response meta-analysis
Karimi, A., Jazani, A. M., Darzi, M., Azgomi, R. N. D., & Vajdi, M. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.07.003 · Cited by 24
da Rocha, T. J. C. M., Melson, E., Zamora, J., Fernandez-Felix, B. M., Arlt, W., & Thangaratinam, S. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad599 · Cited by 24
Sabapathy, K., Mwita, F. C., Dauya, E., Bandason, T., Simms, V. M., Chikwari, C. D., Doyle, A. M., Ross, D. A., Shah, A. S. V., Hayes, R., et al. (2023) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(23)00287-0 · Cited by 27
Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive Vaccine
Hu, X., Deng, Y., Chen, X., Zhou, Y., Zhang, H., Wu, H., Yang, S., Chen, F., Zhou, Z., Wang, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12996-y · Cited by 24
Lemogoum, D., van de Borne, P., Lele, C. E. B., Damasceno, A. A. M., Ngatchou, W., Amta, P., Leeman, M., Preumont, N., Degaute, J.-P., Kamdem, F., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001513 · Cited by 25
Mi, Y., Wu, Q. J., Yuan, W., Chen, F., & Du, D. (2018) · Autonomic Neuroscience · doi:10.1016/j.autneu.2018.06.003 · Cited by 25
Control of blood pressure and cardiovascular outcomes in type 2 diabetes
Vargas‐Uricoechea, H., & Cáceres-Acosta, M. F. (2018) · Open Medicine · doi:10.1515/med-2018-0048 · Cited by 23
The First Brazilian Registry of Hypertension
Lópes, R. D., Barroso, W. K. S., Brandão, A. A., Barbosa, E. C. D., Malachias, M. V. B., Gomes, M. M., Amodeo, C., Póvoa, R., Cavalcante, M. A., Précoma, D. B., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.08.012 · Cited by 24
Multilayered Interplay Between Fructose and Salt in Development of Hypertension
Eren, Ö. C., Ortíz, A., Afşar, B., Covic, A. C., Kuwabara, M., Lanaspa, M. A., Johnson, R. J., & Kanbay, M. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.12150 · Cited by 25
Pontes, V. C. B., Rodrigues, D. P., Caetano, A. L., & Gamberini, M. T. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.03.050 · Cited by 25
Wang, B., Liu, Y., Sun, X., Yin, Z., Li, H., Ren, Y., Zhao, Y., Zhang, R., Zhang, M., & Hu, D. (2020) · Journal of Human Hypertension · doi:10.1038/s41371-020-0314-8 · Cited by 24
Juang, J. J., Binda, A., Lee, S., Hwang, J., Chen, W., Liu, Y., Lin, L.-Y., Yu, C., Ho, L., Huang, H., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102843 · Cited by 24
Pan, H., Lin, H., Chen, W., & Wang, T. (2020) · PubMed Central · doi:10.6515/acs.202007_36(4).20191220a · Cited by 23
Skeete, J., Connell, K., Ordúñez, P., & DiPette, D. J. (2020) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s261031 · Cited by 25
ANKRD36 Is Involved in Hypertension by Altering Expression of ENaC Genes
Yan, Y., Wang, J., Yu, L., Cui, B., Wang, H., Xiao, X., Zhang, Y., Zheng, J., Wang, J., Hui, R., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.319883 · Cited by 24
Renal sympathetic activity: A key modulator of pressure natriuresis in hypertension
Díaz-Morales, N., Baranda-Alonso, E. M., Martínez-Salgado, C., & López-Hernández, F. J. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115386 · Cited by 24
Leung, G., Grant, A., Garas, A. N., Li, G., & Freeman, E. E. (2023) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2023.03.014 · Cited by 23
Mengesha, E. W., Tesfaye, T. D., Boltena, M. T., Birhanu, Z., Sudhakar, M., Hassen, K., Kedir, K., Ayele, F. M., Hailemeskel, E., Dereje, M., et al. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003459 · Cited by 33
Kuria, N., Reid, A. J. S., Owiti, P., Tweya, H. M., Kibet, C. K., Mbau, L. K., Manzi, M., Murunga, V., Namusonge, T., & Kibachio, J. M. (2018) · Tropical Medicine & International Health · doi:10.1111/tmi.13078 · Cited by 23
Oliver-Martínez, P. A., Ramos‐Campo, D. J., Martínez-Aranda, L. M., Martínez‐Rodríguez, A., & Rubio‐Arias, J. Á. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002459 · Cited by 22
“0000000000002459 H igh blood pressure is a disease that affects millions of people worldwide [1].”
BackgroundCurrent genetic engineering strategies for the production of antihypertensive ACEI peptides
Gomes, C. N., Ferreira, D., Carvalho, J. P. F., Barreto, C. A. V., Fernandes, J. P., Gouveia, M., Ribeiro, F., Duque, A. S., & Vieira, S. I. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27373 · Cited by 23
Metadata
- Authors
- Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J., & He, J.
- Affiliations
- Tulane University (US)
- ORCID
- Venue
- Circulation
- Published
- 2016-08-09
- Volume
- 134
- Issue
- 6
- Pages
- 441-450
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC4979614
- OpenAlex
- W2504981678
- Cited by
- 3,531
- References
- 39
- Citations by year
- 2026: 248 · 2025: 362 · 2024: 410 · 2023: 432 · 2022: 468 · 2021: 549 · 2020: 401 · 2019: 331 · 2018: 203 · 2017: 113 · 2016: 10
- FWCI
- 180.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- World Health Organization
- National Heart, Lung, and Blood Institute (U01HL114197, T32HL007024)
- National Institute of General Medical Sciences (P20GM109036)
- Fogarty International Center (D43TW009107)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- hypertension, global health disparities, hypertension prevalence, hypertension awareness, antihypertensive therapy, blood pressure control, low- and middle-income countries, high-income countries, secular trends, global burden of disease
- MeSH terms
- Cross-Sectional Studies, Developing Countries, Humans, Hypertension, Population Surveillance, Global Health, Prevalence, Developed Countries, Healthcare Disparities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
